Cognitive profiles in Mild Cognitive Impairment (MCI) patients associated with Parkinson's disease and cognitive

Michele Pistacchi1, Manuela Gioulis2, Franco Contin3

  • 1Neurology Service, Santorso Hospital, Garziere street 73, Santorso, Italy.

Abstract

Insights

Mild cognitive impairment (MCI) in Parkinson's disease (PD) differs from amnestic MCI. MCI-PD patients show executive and visuospatial deficits, while aMCI patients have memory impairments.

Area of Science:

  • Neurology
  • Cognitive Science
  • Geriatrics

Background:

  • Mild cognitive impairment (MCI) is a common condition in the elderly, with varying causes.
  • MCI in Parkinson's disease (MCI-PD) is a recognized subtype with a variable range of cognitive deficits.
  • Early identification of MCI-PD is crucial for developing targeted therapies.

Purpose of the Study:

  • To differentiate the clinical phenotype of amnestic MCI (aMCI) from MCI in Parkinson's disease (MCI-PD).

Main Methods:

  • Seventy-three patients with aMCI and 38 with MCI-PD were assessed.
  • Cognitive function was evaluated using the Mini-mental State Examination (MMSE), Rey auditory-verbal learning test (Rey-I, Rey-D), and immediate visual memory (IVM) test.
  • Mood was assessed using the Geriatric Depression Scale (GDS).

Main Results:

  • Significant differences were observed in Rey-I, Rey-D, and IVM scores between the aMCI and MCI-PD groups.
  • Patients with aMCI exhibited greater long-term memory impairment compared to MCI-PD patients.
  • aMCI patients generally had better attention, computation, praxis, and conceptualization than MCI-PD patients.

Conclusions:

  • The cognitive deficit profiles are distinct for aMCI and MCI-PD.
  • Memory impairment characterizes aMCI.
  • Executive function and visuospatial attention deficits are typical of MCI-PD.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
726
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
1.1K